To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.

Cost and committee reports

Official records Congress.gov attaches to H.R. 4242.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. CRENSHAW, as printed in the Congressional Record (Vol. 169, No. 108, June 21, 2023, Page H3072):
  Section 8 of article 1 of the Constitution. The single subject of this legislation is: To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy
  Source: Congress.gov, Congressional Record June 21, 2023 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  291 characters

  Congress.gov bill record

  H.R. 4242, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/4242

  Record last updated by Congress.gov

  July 24, 2024

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  cfbf6afe2b54854c2f88d8015b09abdb92613148ebb9dcd792573c68e20ff5ea

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of July 24, 2024). Not every bill gets one.

From the Congress.gov bill record for H.R. 4242, last updated July 24, 2024. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.